Literature DB >> 3678622

Does galactose feeding provide a valid model of consequences of exaggerated polyol-pathway flux in peripheral nerve in experimental diabetes?

G B Willars1, J E Lambourne, D R Tomlinson.   

Abstract

This study was designed to examine the effect of exaggerated polyol-pathway flux on sciatic nerve content of polyols, myo-inositol, and water. Rats with streptozocin-induced diabetes of 3- and 12-wk duration and nondiabetic rats fed for 5 days on a diet containing 20% galactose were employed initially. All three conditions showed marked elevation of nerve polyol content, combined with fructose accumulation in the diabetic rats. Galactose-fed rats showed a significant (P less than .01) increase in nerve water content of approximately 30% (when expressed as water/unit dry wt tissue). Diabetic rats showed no change in nerve water. Both diabetic and galactose-fed rats showed a depletion of nerve free myo-inositol, although the extent of depletion was greater in the latter. All these changes were prevented or attenuated by the aldose reductase inhibitor Statil (ICI 128436). When diabetic rats were fed a 20% galactose diet for 5 days, nerves of 3- but not 12-wk diabetic rats showed marked increases in water content. A more mild degree of galactosemia, induced by 5 or 21 days of feeding a diet containing 10% galactose to nondiabetic rats, provoked an increase in nerve water content associated with polyol levels of a similar order to those seen in diabetes. We do not know why polyol-pathway metabolites cause nerve hyperhydration in galactosemia but not in streptozocin-induced diabetes. Such differences urge caution in the use of galactose feeding to model the consequences of exaggerated polyol-pathway flux in nerve to face questions related to neuronal dysfunction in diabetes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678622     DOI: 10.2337/diab.36.12.1425

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.

Authors:  W G McLean
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

Review 2.  The link between hyperglycaemia and diabetic nephropathy.

Authors:  R G Larkins; M E Dunlop
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

3.  Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs.

Authors:  R L Engerman; T S Kern; M E Larson
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

4.  Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.

Authors:  A L Carrington; C B Ettlinger; N A Calcutt; D R Tomlinson
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

Review 5.  Aldose reductase inhibitors and cataract.

Authors:  M J Crabbe
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

Review 6.  The role of polyols in the pathophysiology of hypergalactosemia.

Authors:  G T Berry
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

7.  Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.

Authors:  J E Lambourne; A M Brown; N Calcutt; D R Tomlinson; G B Willars
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.